Education
About Us
Working with TipRanks
Follow Us
Chidozie Ugwumba Insider Profile
11 Followers
Chidozie Ugwumba, Ten Percent Owner at Clene, holds 753.56K shares in Clene (Ticker: CLNN), holds 2.22M shares in Carisma Therapeutics (Ticker: CARM), holds 3.07M shares in BiomX (Ticker: PHGE). Most recently, Chidozie Ugwumba Sold ― shares of Clene on Jan 07, 2026 for an estimated value of $78.01K.
Profitable Transactions
3 out of 11 Profitable Transactions
Average Return
-21.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Chidozie Ugwumba holds in companies
Most Profitable Insider Trade
The most profitable trade made by Chidozie Ugwumba
Chidozie Ugwumba's Trading History
Clene
Jan 07, 2026
Ten Percent Owner
Informative Sell
78.01K
$4.50M
BiomX
Nov 14, 2022
Exit Form 4 - former 10% owner
Informative Sell
106.11K
$6.88M
Carisma Therapeutics
Mar 09, 2023
Director
Uninformative Buy
―
$99.71K
List of latest transactions for each holding click on a transaction to see Chidozie Ugwumba's performance on stock
You May Also Like
Chidozie Ugwumba insider profile FAQ
What is the percentage of profitable transactions made by Chidozie Ugwumba?
The percentage of profitable transactions made by Chidozie Ugwumba is 27%.
What is the average return per transaction made by Chidozie Ugwumba?
The average return per transaction made by Chidozie Ugwumba is -21.70%.
What stocks does Chidozie Ugwumba hold?
Chidozie Ugwumba holds: CLNN, PHGE, CARM stocks.
What was Chidozie Ugwumba’s latest transaction?
Chidozie Ugwumba latest transaction was an Informative Sell of $78.01K.
What was Chidozie Ugwumba's most profitable transaction?
Chidozie Ugwumba’s most profitable transaction was an Informative Sell of CLNN stock on January 7, 2026. The return on the trade was 4.90%.
What is Chidozie Ugwumba's role in Clene?
Chidozie Ugwumba's role in Clene is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.